 | Up a level |
Perumalsamy, Sangeetha and Zaman Huri, Hasniza and Abdullah, Bashar Mudhaffar and Mazlan, Othman and Wan Ahmad, Wan Azman and Vethakkan, Shireene Ratna D. B. (2023) Genetic markers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. Metabolities, 13 (3). ISSN 2218-1989, DOI https://doi.org/10.3390/metabo13030427.
Hassanein, Mohammed M. and Zaman Huri, Hasniza and Baig, Kauser and Abduelkarem, Abduelmula R. (2023) Determinants and effects of vitamin D supplementation in postmenopausal women: A systematic review. Nutrients, 15 (3). ISSN 2072-6643, DOI https://doi.org/10.3390/nu15030685.
A Wahab, Izyan and Goh, Khang Wen and Akbar Zainal, Zainol and Mohamed Yusof, Najlaa Siham and Zaman Huri, Hasniza and Jacob, Sabrina Anne and Mohamad Alwi, Muhammad Najib Mohamad and Hashim, Rosnani and Ahmad Hisham, Shairyzah and Jamil, Nurdiana (2022) Targeted primary and secondary preventive strategies for depression among Malaysian pharmacy students. International Journal of Environmental Research and Public Health, 19 (15). ISSN 1660-4601, DOI https://doi.org/10.3390/ijerph19159629.
Abousheishaa, Aya Ahmed and Mat Lazim, Nor Hazila and Tang, Song Ling and Sulaiman, Ahmad Hatim and Zaman Huri, Hasniza and Guan, Ng Chong (2022) Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing. Patient Education and Counseling, 105 (7). pp. 2466-2474. ISSN 0738-3991, DOI https://doi.org/10.1016/j.pec.2021.11.007.
Tee, Khim Boon and Ibrahim, Luqman and Mohd Hashim, Najihah and Saiman, Mohd Zuwairi and Zakaria, Zaril Harza and Zaman Huri, Hasniza (2022) Pharmacokinetics and metabolomic profiling of metformin and Andrographis paniculata: A protocol for a crossover randomised controlled trial. Journal of Clinical Medicine, 11 (14). ISSN 2077-0383, DOI https://doi.org/10.3390/jcm11143931.
Tee, Khim Boon and Ibrahim, Luqman and Mohd Hashim, Najihah and Saiman, Mohd Zuwairi and Zakaria, Zaril Harza and Zaman Huri, Hasniza (2022) Pharmacokinetic-pharmacometabolomic approach in early-phase clinical trials: A way forward for targeted therapy in type 2 diabetes. Pharmaceutics, 14 (6). ISSN 1999-4923, DOI https://doi.org/10.3390/pharmaceutics14061268.
Perumalsamy, Sangeetha and Wan Ahmad, Wan Azman and Zaman Huri, Hasniza (2021) Retinol-binding protein-4-a predictor of insulin resistance and the severity of coronary artery disease in Type 2 diabetes patients with coronary artery disease. Biology, 10 (9). ISSN 2079-7737, DOI https://doi.org/10.3390/biology10090858.
Perumalsamy, Sangeetha and Wan Ahmad, Wan Azman and Zaman Huri, Hasniza (2021) Single nucleotide polymorphism rs17173608 in the chemerin encoding gene: Is it a predictor of insulin resistance and severity of coronary artery disease in non-obese type 2 diabetes? Healthcare, 9 (6). ISSN 2227-9032, DOI https://doi.org/10.3390/healthcare9060623.
